Filing Flows › Aptargroup (ATR) › Pharma revenue
Aptargroup (ATR) Pharma revenue by quarter
Aptargroup's Pharma revenue was $454M in Q3 2026 (third quarter 2026), -0.9% from Q2 2026. Over the last 3 quarters it ranged from $439M (Q1 2026) to $458M (Q2 2026).
| Quarter | Pharma revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $454M | -0.9% | — |
| Q2 2026 | $458M | +4% | — |
| Q1 2026 | $439M | — | — |
Q3 2026 at a glance
Aptargroup, Q3 2026: revenue $1.0B (+6% year over year), operating margin 13.2%, net earnings $32.8M, operating cash flow $168M. The chart follows the revenue to costs, profit and cash.
Questions
What is Aptargroup's Pharma revenue?
Aptargroup's Pharma revenue was $454M in Q3 2026 (third quarter 2026), -0.9% from Q2 2026.
How has Aptargroup's Pharma revenue changed?
Over the last 3 quarters it ranged from $439M (Q1 2026) to $458M (Q2 2026).